Human Placental Protein Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Human Placental Protein Market is expected to register a CAGR of around 5% during the forecast period. Rising use of placental protein in cosmetics and medication to treat menopause is among the key factor triggering the growth of the human placental protein market. For instance, several products are in the human placental market which is promoting the revenue growth, Melsmon pharmaceuticals are producing pharmaceutical-grade placenta which is used for treating menopause. In addition, Japan Bio Products has Laennec which treats chronic hepatitis and another company Alber David has Inj.Placentrex. (wound healer).

The increase in R&D investments in healthcare coupled with the introduction of human placental protein in pseudo-medicines will create lucrative opportunities in the human placental protein market.

However, prolonged use of human placental proteins can cause skin dryness which hampers the market.

Key Market Trends

Skin Care Products in Human Placental Protein Segment is Expected to Hold Significant Market Share

Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments.

In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Human Placental Protein market attributing to an increasingly aging population with a higher rate of menopause population in this region. According to the National Institute of Health, approximately 1.3 million women become menopausal each year and 5% experience early menopause in the United States. This is leading to the adoption of placental extract for treating menopausal, thus promote the growth of the human placental protein market. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The market studied is moderately competitive and most of the companies operating in the market are the local players from various countries. Some of the companies which are currently getting the attention in the market are JAPAN BIO PRODUCTS Co., Ltd., VWR International, Takara Bio Inc, Abcam plc, Kamiya Biomedical Co, Scripps Laboratories, Lee BioSolutions and elabscience.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support